Literature DB >> 16000422

Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient.

Francesca Meacci1, Germano Orrù, Elisabetta Iona, Federico Giannoni, Claudio Piersimoni, Gianni Pozzi, Lanfranco Fattorini, Marco R Oggioni.   

Abstract

The emergence and spread of multidrug-resistant (MDR) Mycobacterium tuberculosis (MT) represents a worldwide health care problem because of the difficulty in treating these infections. Development of drug resistance in MT arises mainly by mutation of chromosomal genes. To investigate the evolution of a MT population during a long-lasting infection, the phenotypic and genotypic changes in the drug resistance of 10 sequential MT isolates from a noncompliant chronically infected patient were investigated. During more than 12 years of active disease, a MDR population developed; molecular typing showed one single parental strain that infected the patient and persisted throughout the disease. Molecular analysis of the drug resistance-related genes revealed that discrete subpopulations evolved over time from the parental strain by acquiring and accumulating resistance-conferring mutations to isoniazid, rifampin, and streptomycin. Overall, these observations indicate that during a chronic infection, several subpopulations may coexist in the same patient with different drug susceptibility profiles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000422      PMCID: PMC1169130          DOI: 10.1128/JCM.43.7.3114-3120.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities.

Authors:  S Sreevatsan; X Pan; K E Stockbauer; D L Williams; B N Kreiswirth; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  The population genetics of antibiotic resistance.

Authors:  B R Levin; M Lipsitch; V Perrot; S Schrag; R Antia; L Simonsen; N M Walker; F M Stewart
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 4.  Antibiotic resistance: counting the cost.

Authors:  B G Spratt
Journal:  Curr Biol       Date:  1996-10-01       Impact factor: 10.834

5.  Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.

Authors:  R C Cooksey; G P Morlock; A McQueen; S E Glickman; J T Crawford
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis.

Authors:  A Theisen; C Reichel; S Rüsch-Gerdes; W H Haas; J K Rockstroh; U Spengler; T Sauerbruch
Journal:  Lancet       Date:  1995-06-10       Impact factor: 79.321

7.  Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities.

Authors:  S Sreevatsan; X Pan; Y Zhang; V Deretic; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid.

Authors:  Y Zhang; S Dhandayuthapani; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  B Heym; E Stavropoulos; N Honoré; P Domenech; B Saint-Joanis; T M Wilson; D M Collins; M J Colston; S T Cole
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

10.  Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity.

Authors:  Gilla Kaplan; Frank A Post; Andre L Moreira; Helen Wainwright; Barry N Kreiswirth; Melike Tanverdi; Barun Mathema; Srinivas V Ramaswamy; Gabi Walther; Lafras M Steyn; Clifton E Barry; Linda-Gail Bekker
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more
  13 in total

Review 1.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

2.  Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.

Authors:  Maha R Farhat; Razvan Sultana; Oleg Iartchouk; Sam Bozeman; James Galagan; Peter Sisk; Christian Stolte; Hanna Nebenzahl-Guimaraes; Karen Jacobson; Alexander Sloutsky; Devinder Kaur; James Posey; Barry N Kreiswirth; Natalia Kurepina; Leen Rigouts; Elizabeth M Streicher; Tommie C Victor; Robin M Warren; Dick van Soolingen; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 3.  Evolutionary causes and consequences of bacterial antibiotic persistence.

Authors:  Erik Bakkeren; Médéric Diard; Wolf-Dietrich Hardt
Journal:  Nat Rev Microbiol       Date:  2020-05-27       Impact factor: 60.633

4.  Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.

Authors:  Joseph Shea; Tanya A Halse; Pascal Lapierre; Matthew Shudt; Donna Kohlerschmidt; Patrick Van Roey; Ronald Limberger; Jill Taylor; Vincent Escuyer; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

5.  Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients.

Authors:  Gang Sun; Tao Luo; Chongguang Yang; Xinran Dong; Jing Li; Yongqiang Zhu; Huajun Zheng; Weidong Tian; Shengyue Wang; Clifton E Barry; Jian Mei; Qian Gao
Journal:  J Infect Dis       Date:  2012-09-14       Impact factor: 5.226

6.  Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment.

Authors:  Solomon H Mariam; Jim Werngren; Joakim Aronsson; Sven Hoffner; Dan I Andersson
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

Review 7.  Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.

Authors:  Navisha Dookie; Santhuri Rambaran; Nesri Padayatchi; Sharana Mahomed; Kogieleum Naidoo
Journal:  J Antimicrob Chemother       Date:  2018-05-01       Impact factor: 5.790

8.  Evaluation of molecular-Beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts.

Authors:  Hasan Yesilkaya; Francesca Meacci; Stefan Niemann; Doris Hillemann; Sabine Rüsch-Gerdes; Michael R Barer; Peter W Andrew; Marco R Oggioni
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

9.  Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates.

Authors:  P A Black; M de Vos; G E Louw; R G van der Merwe; A Dippenaar; E M Streicher; A M Abdallah; S L Sampson; T C Victor; T Dolby; J A Simpson; P D van Helden; R M Warren; A Pain
Journal:  BMC Genomics       Date:  2015-10-24       Impact factor: 3.969

10.  Design of FRET Probes for SNP RS1006737, Related to Mood Disorder.

Authors:  Germano Orrù; Mauro Giovanni Carta; Alessia Bramanti
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.